FDA conducts inspection at Rain City Cigar II, LLC in Seattle on Sept. 4, 2024

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA
Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA - Official Website
0Comments

On September 4, 2024, the Food and Drug Administration conducted an inspection of Rain City Cigar II, LLC in Seattle to evaluate its tobacco post-market activities, according to data posted on the FDA’s website.

The FDA’s final report stated that Rain City Cigar II, LLC is not required to implement any corrective actions regarding its management operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Benjamin D. Moncarz Chief Financial Officer - FDA

FDA conducted April 15 inspection of Bloodworks Seattle facility

FDA records show a blood and blood products inspection took place at Bloodworks in Seattle on April 15.

Todd M. Lyons, Acting Director, U.S. Immigration And Customs Enforcement

Drug dealer sentenced to five years after Homeland Security investigation in Seattle

A Honduran man has been sentenced to over five years following a major drug trafficking investigation led by Homeland Security Investigations Seattle. Authorities say he played a key role connecting buyers with suppliers distributing fentanyl pills and methamphetamine throughout the Pacific Northwest.

Dr. Mehmet Oz CMS Administrator

Seattle Medicaid spending on alcohol and drug abuse treatment rises to $16,464,492 in 2024

Seattle saw Medicaid expenditures for Alcohol and Drug Abuse Treatment services climb by 20.6% in 2024, indicating shifts in service utilization and payment trends.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Seattle City Wire.